Tardive Dyskinesia at Psych Update 2024

CE

Full-Spectrum Management of Tardive Dyskinesia With Considerations for Special Populations

Nurses: 1.00 Nursing contact hour, including 1.00 hour of pharmacotherapy credit

Physician Assistants/Physician Associates: 1.00 AAPA Category 1 CME credit

Released: August 16, 2024

Expiration: August 15, 2025

Jeremy A. Schreiber
Jeremy A. Schreiber, MSN, APRN, PMHNP-BC

Pretest

Progress
1 2 3
Course Completed
Please answer the questions below.
1.

Which of the following scales would not be useful for assessment of tardive dyskinesia?

2.

At what interval does the APA recommend screening for tardive dyskinesia in high-risk patients with schizophrenia?

3.

A patient with schizophrenia is treated with long-acting IM risperidone, with good symptom control at a stable dose for several years. Recently he has developed tardive dyskinesia symptoms noticeable to himself and others. Which of the following would NOT be an appropriate treatment option?